Cargando…

Soluble molecule profiling and network analysis of primary Sjögren's Syndrome patient serum

Detalles Bibliográficos
Autores principales:	Tarn, JR, Natasari, A, Mitchell, S, Bowman, S, Price, E, Pease, C, Emery, P, Andrews, J, Bombardieri, M, Sutcliffe, N, Pitzalis, C, Lanyon, P, McLaren, J, Hunter, J, Gupta, M, Regan, M, Cooper, A, Giles, I, Isenberg, D, Young, D, Lendrem, D, Downie, C, Foggo, H, Stocks, P, Edgar, S, Ng, WF
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582419/ http://dx.doi.org/10.1186/1471-2474-14-S1-A2

Ejemplares similares

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines
por: Howard Tripp, Nadia, et al.
Publicado: (2016)

Cardiovascular Risk Factors in Women With Primary Sjögren's Syndrome: United Kingdom Primary Sjögren's Syndrome Registry Results
por: Juarez, M, et al.
Publicado: (2014)

Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome
por: Newton, Julia L, et al.
Publicado: (2012)

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren’s syndrome
por: Hackett, Kate L, et al.
Publicado: (2019)

Exploring the biological basis of fatigue using primary Sjögren's syndrome as a disease model
por: Natasari, Andini Savietri, et al.
Publicado: (2013)

Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome
por: Ng, Wan-Fai, et al.
Publicado: (2016)

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome
por: James, Katherine, et al.
Publicado: (2015)

Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjögren's syndrome
por: Collins, K S, et al.
Publicado: (2013)

Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy
por: Bezzina, Oriana M., et al.
Publicado: (2017)

Assessment of blood clot formation in patients with Primary Sjögren’s syndrome (pSS)
por: Collins, K, et al.
Publicado: (2013)

Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials
por: Tarn, Jessica R, et al.
Publicado: (2019)

Accumulation of Self-Reactive Naïve and Memory B Cell Reveals Sequential Defects in B Cell Tolerance Checkpoints in Sjögren’s Syndrome
por: Corsiero, Elisa, et al.
Publicado: (2014)

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy
por: Fisher, Benjamin A, et al.
Publicado: (2018)

Comorbidities in the UK Primary Sjögren’s Syndrome Registry
por: Tarn, Jessica, et al.
Publicado: (2022)

Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study
por: Davies, Kristen, et al.
Publicado: (2019)

Lymphoid chemokine expression in Sjogren's syndrome: relationship with the lymphoid organization of the periductal inflammatory aggregates
por: Barone, F, et al.
Publicado: (2004)

Primary Sjögren's syndrome: Longitudinal real‐world, observational data on health‐related quality of life
por: Tarn, Jessica, et al.
Publicado: (2022)

Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome
por: Traianos, Emmanuella Young, et al.
Publicado: (2020)

The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome
por: Brown, Sarah, et al.
Publicado: (2014)

Association of FCGR3A and FCGR3B haplotypes with rheumatoid arthritis and primary Sjögren's syndrome
por: Mackie, S, et al.
Publicado: (2005)

Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine
por: Collins, Alexis, et al.
Publicado: (2021)

CXCL13 and CCL21 play a key role in ectopic lymphoneogenesis in Sjögren's syndrome
por: Barone, F, et al.
Publicado: (2003)

Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate
por: Bombardieri, Michele, et al.
Publicado: (2004)

Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome
por: Pepple, Sophanit, et al.
Publicado: (2022)

Efficient IL-18 and IL-18BPc adenoviral gene transfer to cultured murine submandibular gland epithelial cells and successful murine retrograde submandibular duct cannulation to modulate IL-18 function in the salivary gland of animal models of Sjogren's syndrome
por: Bombardieri, M, et al.
Publicado: (2005)

CXCL13, CCL21 and CXCL12 are upregulated in mucosal-associated lymphoid tissue lymphomas in patients with Sjorgen's syndrome and cooperate in the maintenance of the immune response and malignant cell survival
por: Barone, F, et al.
Publicado: (2007)

NKp30 Receptor Upregulation in Salivary Glands of Sjögren’s Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment
por: Pontarini, Elena, et al.
Publicado: (2021)

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome
por: Fisher, Benjamin A, et al.
Publicado: (2017)

Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren’s syndrome: a randomized, phase 2, double-blind, placebo-controlled study
por: Price, Elizabeth, et al.
Publicado: (2022)

Resistance to Rituximab Therapy and Local BAFF Overexpression in Sjögren’s Syndrome-Related Myoepithelial Sialadenitis and Low-Grade Parotid B-Cell Lymphoma
por: Quartuccio, Luca, et al.
Publicado: (2008)

Managing fatigue in patients with primary Sjögren’s syndrome: challenges and solutions
por: Miyamoto, Samira Tatiyama, et al.
Publicado: (2019)

Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma
por: Pontarini, Elena, et al.
Publicado: (2020)

Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome
por: Seror, Raphaele, et al.
Publicado: (2022)

Biological Therapy in Primary Sjögren's Syndrome: Effect on Salivary Gland Function and Inflammation
por: Chowdhury, Farzana, et al.
Publicado: (2021)

CTLA4 polymorphism and primary Sjögren's syndrome
por: Lester, Susan, et al.
Publicado: (2007)

Stratifying primary Sjögren’s syndrome: killers in the balance?
por: Bowman, Simon J., et al.
Publicado: (2015)

That Sepia Case
por: McLaren, D. C.
Publicado: (1887)

Words to Young Homœopaths
por: McLaren, D. C.
Publicado: (1887)

Words to Young Homœopaths
por: McLaren, D. C.
Publicado: (1887)

Cases from Practice
por: McLaren, D. C.
Publicado: (1881)

Cannot write session to /tmp/vufind_sessions/sess_lv9s622tf03pfa30v0p7b7t3dk